4Li D, Mallory T. AFP-L3 : a new generation of tumor marker for hepatocellular carcinoma. Clin Chim Acta,2001,313 :15-19.
5Leerapun A, Suravarapu SV, Bida JP, et al. The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population. Clin Gastroenterol Hepatol, 2007, 5: 394-402.
6FDA Class Ⅱ Special Controls Guideline Document: AFP-L3% Immunological Test Systems ( FDA-2005-0030-0001 ) ,2005.
7Kumada T, Nakano S, Takeda I, et al. Clinical utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in small hepatocellular carcinoma: special reference to imaging diagnosis. J Hepatol, 1999, 30 : 125-130.
8[1]Purves LR,Merwe VE,Bersohn I,et al.Variants of α1-fetoprotein[J].Lancet,1970,2:464.
9[2]Taketa K,Endo Y,Sekiya C,et al.A collaborative study for the evaluation of lectin reactive A-fetoproteins in early detection of HCC[J].Cancer Res.1993，53:5419-5423.
10[3]Shiraki K,Takase K,Tameda Y,et al.A clinical study of lectin reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients[J].Hepatology,1995，22(3):802-807.
1Pang RW,Joh JW,Johnson PJ,et al. Biology of hepa tocellular carcinoma EJ. Ann Surg Oncol, 2008, 15 (4) :962-971.
2Malaguarnera M,Di Rosa M,Nicoletti F, et al. Mo- lecular mechanisms involved in NAFLD progression [J]. J Mol Med (Berl) ,2009,87(7) ..679-695.
3Humphrey LL, Fu R, Rogers K, et al. Homocysteine level and coronary heart disease incidence:a systemat- ic review and meta-analysis E J. Mayo Clin Proe, 2008,83(11) :1203-1212.
